The good news this week was Aducanumab seeming to be in a ditch with no tow truck. That has nothing to do with Anavex except the playing field lost a big competitor and the train will keep chugging along.
I predict full enrollment announcement tomorrow and an update or two on the timing of things. Anavex has added many sites for the Alzheimer’s study, maybe more than needed for just the P2b/3 so it would be awesome to learn there’s been a submission for P-4. Not sure that can happen without data readouts but I don’t know. Maybe we'll hear about FDA doings.
It seems like he should have data by now but the cancer trial data took 300 days average so maybe he doesn’t? Trials have completed, more trials are planned, waiting to find out if there has been a delay or it could be things are going to plan.
The Market was in tank mode, dragging on the pps. The Colonial Pipeline is pumping again so maybe we’ll see an up day tomorrow.
Market Data 
Markets 
AI
